Cuardaigh le haghaidh roghanna malartacha:
harm » farm (Leathnaigh an cuardach)
removed. » resolved. (Leathnaigh an cuardach)
resolve. » resolved. (Leathnaigh an cuardach)
harm » farm (Leathnaigh an cuardach)
removed. » resolved. (Leathnaigh an cuardach)
resolve. » resolved. (Leathnaigh an cuardach)
-
61
-
62
Development of immune factors over visits in the AAF and AAF-syn treatment group as (A) scores and (B) loadings.
Foilsithe / Cruthaithe 2025 -
63
Results of comparing visits within allergy groups using linear mixed models and post hoc analysis.
Foilsithe / Cruthaithe 2025 -
64
Results of comparing allergy groups within visits using linear mixed models and post hoc analysis.
Foilsithe / Cruthaithe 2025 -
65
-
66
Results of comparing treatment groups within visits using linear mixed models and post hoc analysis.
Foilsithe / Cruthaithe 2025 -
67
-
68
Results of comparing visits within treatment groups using linear mixed models and post hoc analysis.
Foilsithe / Cruthaithe 2025 -
69
-
70
-
71
Results of comparing treatment groups within visits using KEGG pathway enrichment in ConsensusPathDB.
Foilsithe / Cruthaithe 2025 -
72
Results of comparing allergy groups within visits using KEGG pathway enrichment in ConsensusPathDB.
Foilsithe / Cruthaithe 2025 -
73
-
74
Results of comparing visits within treatment groups using KEGG pathway enrichment in ConsensusPathDB.
Foilsithe / Cruthaithe 2025 -
75
-
76
Results of comparing visits within allergy groups using KEGG pathway enrichment in ConsensusPathDB.
Foilsithe / Cruthaithe 2025 -
77
Potential mechanisms for persistent CMA (left) and resolution of CMA (right) revealed by our study.
Foilsithe / Cruthaithe 2025 -
78
-
79
Interaction between the CFTR protein with drug molecules upon Molecular Docking.
Foilsithe / Cruthaithe 2025Ábhair: -
80